Patent · US Active

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

US9464135B2 · kind B2 · utility

0Cited by

29References

20Claims

0Family size

Assignees

The Regents of the University of California · US
THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS · US

Inventors

Lynn K. Gordon · Calabasas, US
Shawn A. Morales · Pasadena, US
David Telander · Rancho Cordova, US
Jonathan Braun · Calabasas, US

Key dates

Filing date	Nov 18, 2010
Grant date	Oct 11, 2016
Priority date	—
Expiry date	Nov 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of preventing retinal detachment associated with proliferative vitreoretinopathy are provided by administering agents which antagonize the activity or function of EMP2 to subjects at risk of the detachment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.